A detailed history of Simplex Trading, LLC transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 10,166 shares of ACRS stock, worth $11,894. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,166
Previous 28,064 63.78%
Holding current value
$11,894
Previous $34,000 67.65%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

SELL
$1.01 - $1.36 $18,076 - $24,341
-17,898 Reduced 63.78%
10,166 $11,000
Q1 2024

Apr 25, 2024

BUY
$0.92 - $1.44 $25,818 - $40,412
28,064 New
28,064 $34,000
Q3 2023

Nov 01, 2023

BUY
$6.56 - $10.95 $177,651 - $296,536
27,081 Added 1155.83%
29,424 $201,000
Q2 2023

Aug 04, 2023

SELL
$7.89 - $10.64 $972,710 - $1.31 Million
-123,284 Reduced 98.13%
2,343 $24,000
Q1 2023

Apr 27, 2023

BUY
$7.07 - $17.95 $887,525 - $2.25 Million
125,534 Added 134982.8%
125,627 $1.02 Million
Q4 2022

Feb 02, 2023

SELL
$14.33 - $18.37 $12,596 - $16,147
-879 Reduced 90.43%
93 $1,000
Q3 2022

Nov 04, 2022

BUY
$13.07 - $18.22 $12,704 - $17,709
972 New
972 $15,000
Q2 2022

Aug 03, 2022

SELL
$10.16 - $17.08 $126,817 - $213,192
-12,482 Closed
0 $0
Q1 2022

May 02, 2022

SELL
$9.74 - $17.92 $114,123 - $209,968
-11,717 Reduced 48.42%
12,482 $215,000
Q4 2021

Feb 23, 2022

BUY
$12.27 - $18.49 $244,860 - $368,986
19,956 Added 470.33%
24,199 $351,000
Q3 2021

Oct 28, 2021

SELL
$13.38 - $18.8 $3,960 - $5,564
-296 Reduced 6.52%
4,243 $73,000
Q2 2021

Aug 12, 2021

SELL
$17.08 - $29.6 $161,132 - $279,246
-9,434 Reduced 67.52%
4,539 $79,000
Q1 2021

Apr 26, 2021

BUY
$5.86 - $27.73 $59,045 - $279,407
10,076 Added 258.56%
13,973 $352,000
Q4 2020

Feb 02, 2021

BUY
$2.65 - $7.61 $1,857 - $5,334
701 Added 21.93%
3,897 $25,000
Q3 2020

Oct 14, 2020

BUY
$1.5 - $2.71 $4,021 - $7,265
2,681 Added 520.58%
3,196 $8,000
Q2 2020

Jul 13, 2020

BUY
$1.04 - $1.73 $535 - $890
515 New
515 $0
Q1 2020

Apr 29, 2020

SELL
$0.75 - $2.18 $189 - $549
-252 Closed
0 $0
Q4 2019

Feb 05, 2020

SELL
$1.02 - $1.97 $1,695 - $3,274
-1,662 Reduced 86.83%
252 $0
Q3 2019

Oct 15, 2019

SELL
$0.79 - $2.47 $2,159 - $6,752
-2,734 Reduced 58.82%
1,914 $2,000
Q2 2019

Jul 26, 2019

BUY
$2.13 - $7.06 $5,618 - $18,624
2,638 Added 131.24%
4,648 $10,000
Q1 2019

Apr 18, 2019

BUY
$5.63 - $7.84 $9,233 - $12,857
1,640 Added 443.24%
2,010 $0
Q4 2018

Jan 16, 2019

BUY
$6.3 - $15.4 $2,331 - $5,698
370 New
370 $2,000

Others Institutions Holding ACRS

About Aclaris Therapeutics, Inc.


  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $78M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.